BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11548097)

  • 1. Pneumococcal bacteraemia and opportunities for prevention.
    Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
    N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed opportunities in vaccination of patients with subsequent pneumococcal bacteraemia.
    Weightman NC; Walters A
    Br J Gen Pract; 2003 Jul; 53(492):547-9. PubMed ID: 14694668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
    Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
    Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; PĂ©rez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumococcal bacteremia in Hvidovre Hospital 1986-1990].
    Jensen C; Nielsen CM; Kolmos HJ
    Ugeskr Laeger; 1993 Nov; 155(45):3665-70. PubMed ID: 8256359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.
    Hill PC; Birch M; Chambers S; Drinkovic D; Ellis-Pegler RB; Everts R; Murdoch D; Pottumarthy S; Roberts SA; Swager C; Taylor SL; Thomas MG; Wong CG; Morris AJ
    Intern Med J; 2001 Mar; 31(2):97-103. PubMed ID: 11480485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early predictors of mortality in pneumococcal bacteraemia.
    Balakrishnan I; Crook P; Morris R; Gillespie SH
    J Infect; 2000 May; 40(3):256-61. PubMed ID: 10908020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.
    Greene CM; Kyaw MH; Ray SM; Schaffner W; Lynfield R; Barrett NL; Long C; Gershman K; Pilishvili T; Roberson A; Zell ER; Whitney CG; Bennett NM;
    Clin Infect Dis; 2006 Jul; 43(2):141-50. PubMed ID: 16779739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
    Mangtani P; Roberts JA; Hall AJ; Cutts FT
    Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
    Singh KP; Voolmann T; Lang SD
    N Z Med J; 1992 Oct; 105(943):394-5. PubMed ID: 1461592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
    Schembri S; Morant S; Winter JH; MacDonald TM
    Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
    Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.